Form 4 for RMD ResMed|
Accepted 2023-11-29 00:00:00 ET · period of report 2023-11-27 · accession 0001127602-23-028436 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-29 | 2023-11-27 | RMD | Sandercock Brett | CFO | S - Sale | $152.62 | -3,000 | 93.0K | -3% | -$457.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2023-11-27 | S | D | 3,000 | $152.62 | 92,962 | D | — | — | (F1) Includes 47.925 shares of ResMed stock purchased on October 31, 2023, through the ResMed Employee Stock Purchase Plan. |